Novartis: This Big Pharma Giant Could Be a Sleep?at?Night Core Holding for Decades
2026-02-22 15:07:00 ET
Novartis (NYSE: NVS) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and cardiovascular, renal, and metabolic diseases. With a strong operating history and a diversified business,
The pharmaceutical giant could be an attractive stock for more conservative investors. Let's dive in and take a closer look to see why.
Novartis is one of the world's largest healthcare companies . That alone doesn't make it worth buying, but it speaks to the scale of the business and its historical success. A company doesn't achieve this level of scale and industry dominance by accident. Management is doing something right, and the drugmaker has been operating at a high level for years.
NASDAQ: NVS
NVS Trading
-0.73% G/L:
$146.57 Last:
814,258 Volume:
$148.77 Open:
